BioCryst Pharmaceuticals Inc (BCRX) Insider Trading

Total insider buys:
  • $10,508,658.44
Total insider sells:
  • $40,804,433.76
Most recent insider trade:
  • May 14, 2024
Most active insider trader:
  • Thomas R Staab II
Trader NameDateTitleAmountPriceTypeTotal Value
July 1, 2014CFO3,125$13.00Sell$40,625.00
June 23, 2014CFO3,125$12.49Sell$39,031.25
June 17, 2014CFO3,125$12.00Sell$37,500.00
March 14, 2014CFO3,125$11.24Sell$35,125.00
March 6, 2014Director12,665$12.69Sell$160,718.85
Nov. 12, 2013Director3,000$6.19Buy$18,570.00
Aug. 1, 2013Major Shareholder1,136,364$4.40Buy$5,000,001.60
March 5, 2013Director3,000$1.23Buy$3,690.00
Dec. 14, 2012Director20,000$1.51Buy$30,200.00
First«3 of 3»Last
  • Insiders are both buying and selling BioCryst Pharmaceuticals Inc stock.

  • The insider traders at BioCryst Pharmaceuticals Inc are: Thomas R Staab II, Lynne Powell, William P Sheridan, Yarlagadda S Babu, Bros. Advisors Lp Baker, George B Abercrombie, Jon P Stonehouse, Alane P Barnes, Anthony Doyle, Helen M Thackray, Nancy J Hutson, Michael L Jones, Steve Aselage, Machelle Sanders, Megan Sniecinski, Vincent Milano, Kenneth B Lee Jr, Peder Jensen, George B. Abercrombie, Steven K Galson, Felix Baker, Thomas Staab II, George Abercrombie, Kenneth Lee, Jr., and Fred E Cohen

  • The most active insider trader at BioCryst Pharmaceuticals Inc is Thomas R Staab II with 35 trades.

  • Bros. Advisors Lp Baker has sold the most BioCryst Pharmaceuticals Inc stock with a total value of $40,465,900.00.

  • Felix Baker has bought the most BioCryst Pharmaceuticals Inc stock with a total value of $10,000,003.20.

  • The most recent insider trade for BioCryst Pharmaceuticals Inc was on May 14, 2024.

  • The single biggest insider buy for BioCryst Pharmaceuticals Inc was from Felix Baker with a total value of $5,000,001.60 on Aug. 1, 2013.

  • The single biggest insider sell for BioCryst Pharmaceuticals Inc was from Bros. Advisors Lp Baker with a total value of $20,232,950.00 on Aug. 16, 2016.